Kura Oncology, Inc.
$50 Million - Follow-OnJoint Bookrunner
Aclaris Therapeutics Inc.
$86 Million - Follow-OnJoint Bookrunner
$120 Million - Initial Public OfferingJoint Bookrunner
Hospital Utility Survey: Upside for MCOs, Earnings Achievability for Hospitals
ALGN / Bullish MEDACorp Call For ALGN; Teen May Be Nearing An Inflection
VRTX / Plenty of Promising Signs in Mgmnt Meeting – Is VX-445 the Best?